FDA Inspection 1064657 — Baxter Healthcare Corporation
The FDA completed an inspection of Baxter Healthcare Corporation on August 17, 2018 in Aibonito, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 17, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Aibonito, PR (United States)